Hikma Pharmaceuticals (HIK) Pharma and Biotech Sector

  • Latest quote

    1,818.00p (mid)

  • Current Change (%)

    1.86%

  • Price

    Bid: 1,807.50p

    Offer: 1,808.00p

  • Today

    High: 1,826.00p

    Low: 1,788.50p

  • This year

    High: 1,826.00p

    Low: 855.60p

  • Information

    Volume: 568,420

    Market Cap: £4357.28M


Hikma Pharmaceuticals Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Hikma Pharmaceuticals RNS Feed

Title Release date
Half-year Report 07:00 - August 15, 2018
Notice of Results 09:00 - July 23, 2018
Hikma enters licensing partnership with Perrigo 09:00 - July 9, 2018
Total Voting Rights 16:56 - July 2, 2018
Director/PDMR Shareholding 15:24 - June 15, 2018
Director/PDMR Shareholding 11:50 - June 8, 2018
Director/PDMR Shareholding 10:29 - June 4, 2018
Hikma appoints Chief Transformation Officer 09:00 - June 4, 2018
Total Voting Rights 11:34 - June 1, 2018
Director/PDMR Shareholding 15:20 - May 30, 2018
Hikma launches Methylergonovine Maleate Tablets 09:00 - May 30, 2018
Director/PDMR Shareholding 10:20 - May 23, 2018
AGM Results 13:01 - May 18, 2018
Trading Statement 07:00 - May 18, 2018
Director/PDMR Shareholding 13:45 - May 17, 2018

NOTE: This is based on 61 open tips for this company


Total Number of Share tips :

97

View all Hikma Pharmaceuticals Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today